Liminal BioSciences
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-26.68172.17-37.86-13.32-9.85-1.12-0.74-1.07-0.92-0.47519.43-9.85
Price/Sales ratio
21.3144.4378.6681.9527.654.6535.6139.4764.6234.06647.6727.65
Price/Book Value ratio
21.6414.6117.0210.148.86-3.891.705.660.970.377.177.17
Price/Cash Flow ratio
-25.77-39.39-42.27-13.75-8.82-2.67-1.75-1.72-0.41-0.42-8.16-8.82
Price/Free Cash Flow ratio
-17.80-29.23-36.70-11.86-8.15-2.51-1.68-1.67-0.41-0.42-8.15-2.51
Price/Earnings Growth ratio
0.00-1.330.03-0.150.54-0.010.000.010.010.01-0.00-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
68.05%69.51%66.49%58.77%74.05%19.78%43.65%38.70%100%100%N/A19.78%
Operating Profit Margin
-48.93%11.19%-204.35%-655.07%-314.57%-239.66%-4295.06%-2842.11%-7707.15%-8223.19%-8170.32%-239.66%
Pretax Profit Margin
-83.64%-2.08%-252.40%-713.07%-344.59%-544.42%-4781.01%-3688.21%-6989.89%-7341.89%-7341.89%-544.42%
Net Profit Margin
-79.87%25.81%-207.71%-614.97%-280.53%-412.39%-4776.18%-3682.15%-7008.24%-7210.97%124.68%-280.53%
Effective Tax Rate
-0.75%636.66%8.29%5.31%10.94%7.76%0.10%0.16%-0.26%1.78%N/A7.76%
Return on Assets
-33.06%2.91%-23.67%-37.99%-38.65%-189.87%-141.86%-103.69%-35.74%-57.30%0.99%-38.65%
Return On Equity
-81.09%8.48%-44.95%-76.15%-89.95%345.14%-229.20%-528.75%-105.68%-79.86%1.46%-89.95%
Return on Capital Employed
-40.28%1.55%-24.88%-46.03%-49.64%-169.05%-157.38%-100.28%-46.07%-81.71%-81.18%-81.18%
Liquidity Ratios
Current Ratio
1.421.133.262.002.001.143.033.07N/AN/A4.082.00
Quick Ratio
1.261.072.861.571.000.802.792.676.194.083.791.00
Cash ratio
0.700.712.110.860.640.201.961.895.863.673.670.64
Days of Sales Outstanding
249.12200.99125.20195.54102.22153.88989.90429.48606.251.07K1.07K102.22
Days of Inventory outstanding
164.89134.55243.89737.661.29K115.52994.991.68KN/AN/AN/A115.52
Operating Cycle
414.01335.54369.10933.211.39K269.411.98K2.11KN/AN/AN/A269.41
Days of Payables Outstanding
257.39473.58490.45770.66695.29202.631.38K1.64KN/AN/AN/A202.63
Cash Conversion Cycle
156.62-138.04-121.35162.54702.1066.77598.35469.69N/AN/AN/A66.77
Debt Ratios
Debt Ratio
0.250.110.100.180.321.290.280.620.480.020.281.29
Debt Equity Ratio
0.630.340.190.370.75-2.350.463.201.420.040.39-2.35
Long-term Debt to Capitalization
0.240.250.160.240.411.830.270.740.550.020.021.83
Total Debt to Capitalization
0.380.250.160.270.431.730.310.760.580.030.031.73
Interest Coverage Ratio
-9.28-5.48-18.49-22.89-15.40-10.35-15.86-10.78N/AN/A-10.95-15.40
Cash Flow to Debt Ratio
-1.32-1.09-2.02-1.94-1.32-0.61-2.11-1.02-1.63-21.39-21.39-0.61
Company Equity Multiplier
2.452.901.892.002.32-1.811.615.092.951.391.39-1.81
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.82-1.12-1.86-5.95-3.13-1.74-20.26-22.88-154.90-79.35-79.35-1.74
Free Cash Flow / Operating Cash Flow Ratio
1.441.341.151.151.081.061.041.021.001.001.001.06
Cash Flow Coverage Ratio
-1.32-1.09-2.02-1.94-1.32-0.61-2.11-1.02-1.63-21.39-21.39-0.61
Short Term Coverage Ratio
-2.63N/AN/A-14.35-18.46-9.10-11.75-10.92-13.84-43.29-43.29-9.10
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A